| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 158.688 | 158.829 | 172.983 | 193.017 | 185.966 | 163.647 | 224.507 | 267.679 | 258.829 | 279.584 |
| Total Income - EUR | 158.888 | 159.310 | 177.181 | 193.342 | 202.962 | 163.771 | 224.647 | 267.757 | 258.870 | 301.597 |
| Total Expenses - EUR | 148.543 | 132.649 | 140.796 | 155.503 | 176.548 | 144.854 | 167.824 | 206.134 | 191.661 | 193.062 |
| Gross Profit/Loss - EUR | 10.345 | 26.661 | 36.384 | 37.839 | 26.414 | 18.917 | 56.822 | 61.624 | 67.209 | 108.535 |
| Net Profit/Loss - EUR | 8.253 | 21.673 | 33.829 | 36.032 | 24.384 | 17.391 | 54.577 | 58.947 | 64.621 | 99.487 |
| Employees | 12 | 13 | 12 | 0 | 7 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Epimedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 171.444 | 203.738 | 214.554 | 171.180 | 174.524 | 134.205 | 120.350 | 93.680 | 76.017 | 134.548 |
| Current Assets | 16.625 | 7.126 | 15.706 | 43.766 | 22.087 | 51.416 | 69.606 | 60.857 | 113.594 | 49.631 |
| Inventories | 0 | 0 | 0 | 226 | 221 | 1.655 | 3.798 | 3.309 | 2.188 | 1.557 |
| Receivables | 0 | 0 | 0 | 6.253 | 0 | 1.087 | 4.202 | 1.732 | 1.531 | 4.004 |
| Cash | 16.625 | 7.126 | 15.706 | 37.287 | 21.866 | 48.674 | 61.606 | 55.816 | 109.875 | 44.070 |
| Shareholders Funds | 11.687 | 21.720 | 48.176 | 75.030 | 63.514 | 79.700 | 114.647 | 95.478 | 159.809 | 149.845 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 135.506 | 189.144 | 169.492 | 139.916 | 133.097 | 105.920 | 75.309 | 59.060 | 29.802 | 34.335 |
| Income in Advance | 45.872 | 29.107 | 12.593 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Epimedica Srl